Citigroup’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$38.5K Buy
2025
Q1
$22.7K Sell
2024
Q4
$74.2K Buy
2024
Q3
$78.5K Buy
2024
Q2
$29.5K Buy
2024
Q1
$32.4K Buy
2023
Q4
$10.1K Buy
2023
Q3
$2.2K Sell
2023
Q2
$36.2K Buy
2023
Q1
$2.56K Buy